We hypothesized that an interrogation of the phosphoproteome might inform about mechanistic traits not capturable in gene-centric layers19,20, aiming to understand the basic kinome landscapes underlying the response to the cytotoxic agent paclitaxel in HER2-negative breast cancer. The gene discussed is ERBB2; the disease is breast cancer.